shopping cart Your cart is empty
  • Home
  • Medical Devices
  • Hemostasis Analyzers Market By Type Of Test (Prothrombin Time (PT/INR) Testing Kits, D Dimer Testing Kits, Fibrinogen Testing Kits...

Hemostasis Analyzers Market By Type Of Test (Prothrombin Time (PT/INR) Testing Kits, D Dimer Testing Kits, Fibrinogen Testing Kits), By Technology (Mechanical, Optical, Electrochemical), By End Users (Research Institutes, Diagnostic Laboratories, Standalone Hospitals), By Product Type (Clinical Laboratory Analyzers, Consumables, Hemostasis Analyzers For Point-Of-Care Testing) , Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Jul 27, 2016

Key Findings


The global hemostasis analyzers marketis expected to grow with a robust CAGR of 9.7 % during 2016-2022, and is estimated to have a market value of around $4,500 million by 2022.Increasing incidences of blood clotting diagnosis for patients mainly who are more prone to lose excess blood from body during surgeries is anticipated to drive the market growth for global hemostasis analyzer or coagulation testing market over the forecast period. Hemostasis analyzers are instruments supporting the medical practitioners for treating patients with blood clotting or bleeding disorder. Continuous innovation in technology has led to the introduction of manynovel drugsand devicessuch as high throughput hemostasis analyzers, is estimated to boost the global hemostasis analyzers marketgrowth over the forecast period.


Additionally,strong government support; increasing demand for technological advancements for medical treatment; and,growing trend in laboratory automation market is anticipated to drive the global hemostasis analyzer market. Enormous investments in R&D coupled with growing awareness among the global population provide significant growth opportunity for this market during the forecast period.The growing number of campaigns in emerging economies,along withhigh rate of adoption of automated hemostasis equipment in diagnostic laboratories areexpected to create huge potential forgrowth of global hemostasis analyzers market by 2022.


The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in monoclonal antibodies, immunoassays, molecular diagnostics,chromogenic substrates, computers and laboratory automation will fundamentally change the global coagulation diagnostics practice during the forecast year. New specific and sensitive markers of coagulation will be gradually used on automated instrumentation. Coagulation testing will also become more uniform, offering opportunities for quality control services and products. Furthermore, the continuing contraction of the technological advances and hospital system will facilitate decentralization of the coagulation testing closer to the patient, therefore, creating additional challenges and opportunities for the suppliers.


Market Segment Insight


Theglobal hemostasis analyzers market is majorly segmented intoend user, product,and regional outlook.In the type of test segment, market is divided intoProthrombin Time (PT/INR) Testing Kits; Activated Clotting Time (ACT/APTT) Testing Kits; D Dimer Testing Kits; Fibrinogen Testing Kits; and, other Testing Kits. Tests will be done according to amount of blood loss by the patient.In technology segment, the market is divided into mechanical, optical, electrochemical, and others. Mechanical hemostasis analyzers is expected to witness considerable growth in the market share, mainly due to more accurate, sophisticated, and efficient management at a lower cost. In end user segment, the market is divided into research institutes, diagnostic laboratories, standalone hospitals, and other end users. Owing to the adoption of latest technology and heavy budgetary expenditure the medical and research institutes are likely to witness beneficial growth over the forecast period. In product type segment, market is divided into clinical laboratory analyzers, consumables, and hemostasis analyzers for point-of-care testing. Clinical laboratory analyzers is subdivided into hemostasis analyzers, which is again subdivided into automated hemostasis analyzers, semi-automated hemostasis analyzers, and manual hemostasis analyzers. Consumables segment is subdivided into reagents and standards; and, controls and calibrations. Hemostasis analyzers subdivision of clinical laboratory analyzers is expected to witness lucrative growth over the forecast time period due to rising demand for automated hemostasis analyzers in medical diagnosis.


In regional outlook, the market is divided into North America, Europe, Asia Pacific, and Rest of the World. Asia Pacific region is growing at a higher rate than other regions. North America dominates the global hemostasis analyzers market due to developed healthcare infrastructure and technological advancement. Rest of the world is expected to display sluggish growth rate in the forecasttime period.


Regional Insight


Globally, the hemostasis analyzers market is divided into North America, Europe, Asia Pacific, and Rest of the World. North American region is expected to dominate the global hemostasis analyzers market during the forecast time period. Due torising R&D activities; developed healthcare infrastructure;rising incidences of surgeries & organ transplant procedures; and,growing prevalence of hemostasis disorders are factors that are expected to maintain the dominance of this region over the forecast period. Asia Pacific region is anticipated to show the highest CAGR during the forecast period, and it is the fastest growing region majorly due to increasing awareness about hemostasis coupled with rising number of campaigns and government initiatives in this region. European region is also expected to show positive growth over the forecast time period. Rest of the world is projected to have sluggish growth rate, but penetration of market players in these regionsare expected to show positive growth in the forecast period.


Competitive Insights


Some ofthekey market players areNihol Kohden Corporation; Beckman Coulter;International Laboratory Werfen Group;Transasia Bio Medical Ltd.; Thermo Fisher Scientific, Inc.; Sysmex Corporation; Siemens Healthcare; etc.Acquisitions, new product development, collaborations, joint ventures, mergers and expansions are the key strategies adopted by the market players to sustain in the market.

CHAP 1. METHODOLOGY & SCOPE 14
1.1. RESEARCH METHODOLOGY 14
1.2. RESEARCH SCOPE & ASSUMPTIONS 14
1.3. LIST OF DATA SOURCES 14


CHAP 2. EXECUTIVE SUMMARY 15
2.1. GLOBAL HEMOSTASIS ANALYZERS MARKET SUMMARY & KEY BUYING CRITERIA 15
2.2. GLOBAL HEMOSTASIS ANALYZERS MARKET OUTLOOK 15
2.3. MARKET SEGMENTATION ANALYSIS 15
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 15
2.5. GLOBAL HEMOSTASIS ANALYZERS MARKET VALUE CHAIN ANALYSIS 15
2.6. VENDOR LANDSCAPE 15


CHAP 3. GLOBAL HEMOSTASIS ANALYZERS MARKET 16
3.1. MARKET DRIVER ANALYSIS 16
3.1.1. DEVELOPMENT OF HIGH THROUGHPUT HEMOSTASIS ANALYZERS 16
3.1.2. FOCUS OF KEY PLAYERS ON THE DEVELOPMENT OF TECHNOLOGICALLY ADVANCED HEMOSTASIS/COAGULATION ANALYZER 16
3.1.3. INCREASING ADOPTION OF AUTOMATED HEMOSTASIS INSTRUMENTS BY DIAGNOSTIC LABORATORIES 16
3.1.4. DEVELOPMENT OF HIGH-SENSITIVITY POINT-OF-CARE (POC) HEMOSTASIS TESTING 16
3.1.5. LARGE NUMBER OF AWARENESS CAMPAIGNS/ CONFERENCES IN DEVELOPING COUNTRIES 16
3.2. MARKET RESTRAINT ANALYSIS 16
3.2.1. SLOW ADOPTION OF ADVANCED HEMOSTASIS INSTRUMENTS IN EMERGING ECONOMIES 16
3.2.2. HIGH COST OF FULLY AUTOMATED HEMOSTASIS ANALYZERS 16
3.3. KEY OPPORTUNITIES 16
3.3.1. RAPID GROWTH OF HEMOSTASIS MARKET IN EMERGING COUNTRIES 16
3.3.2. GROWING INCLINATION TOWARDS POINT-OF-CARE (POC) HEMOSTASIS ANALYZERS 16
3.4. CHALLENGES 16
3.4.1. EDI MANAGEMENT 16


CHAP 4. INDUSTRY ANALYSIS 17
4.1. GLOBAL HEMOSTASIS ANALYZERS MARKET– PORTER’S FIVE FORCE MODEL 17
4.2. GLOBAL HEMOSTASIS ANALYZERS MARKET– PESTEL ANALYSIS 17
4.3. GLOBAL HEMOSTASIS ANALYZERS MARKET– GAP ANALYSIS 17


CHAP 5. GLOBAL HEMOSTASIS ANALYZERS MARKET BY TYPE OF TEST 2012-2022 ($ MILLION) 18
5.1. GLOBAL HEMOSTASIS ANALYZERS MARKET BY PROTHROMBIN TIME (PT/INR) TESTING KITS MARKET 2012-2022 ($ MILLION) 18
5.2. GLOBAL HEMOSTASIS ANALYZERS MARKET BY ACTIVATED CLOTTING TIME (ACT/APTT) TESTING KITS MARKET 2012-2022 ($ MILLION) 18
5.3. GLOBAL HEMOSTASIS ANALYZERS MARKET BY D DIMER TESTING KITS MARKET 2012-2022 ($ MILLION) 18
5.4. GLOBAL HEMOSTASIS ANALYZERS MARKET BY FIBRINOGEN TESTING KITS MARKET 2012-2022 ($ MILLION) 18
5.5. GLOBAL HEMOSTASIS ANALYZERS MARKET BY OTHERS TESTING KITS MARKET 2012-2022 ($ MILLION) 18


CHAP 6. GLOBAL HEMOSTASIS ANALYZERS MARKET BY TECHNOLOGY 2012-2022 ($ MILLION) 19
6.1. GLOBAL HEMOSTASIS ANALYZERS MARKET BY MECHANICAL 2012-2022 ($ MILLION) 19
6.2. GLOBAL HEMOSTASIS ANALYZERS MARKET BY OPTICAL 2012-2022 ($ MILLION) 19
6.3. GLOBAL HEMOSTASIS ANALYZERS MARKET BY ELECTROCHEMICAL 2012-2022 ($ MILLION) 19
6.4. GLOBAL HEMOSTASIS ANALYZERS MARKET BY OTHERS 2012-2022 ($ MILLION) 19


CHAP 7. GLOBAL HEMOSTASIS ANALYZERS MARKET BY END USERS 2012-2022 ($ MILLION) 20
7.1. GLOBAL HEMOSTASIS ANALYZERS MARKET BY RESEARCH INSTITUTES 2012-2022 ($ MILLION) 20
7.2. GLOBAL HEMOSTASIS ANALYZERS MARKET BY DIAGNOSTIC LABORATORIES 2012-2022 ($ MILLION) 20
7.3. GLOBAL HEMOSTASIS ANALYZERS MARKET BY STANDALONE HOSPITALS 2012-2022 ($ MILLION) 20
7.4. GLOBAL HEMOSTASIS ANALYZERS MARKET BY OTHERS END USERS 2012-2022 ($ MILLION) 20


CHAP 8. GLOBAL HEMOSTASIS ANALYZERS MARKET BY PRODUCT TYPE 2012-2022 ($ MILLION) 21
8.1. GLOBAL HEMOSTASIS ANALYZERS MARKET BY CLINICAL LABORATORY ANALYZERS 2012-2022 ($ MILLION) 21
8.2. GLOBAL HEMOSTASIS ANALYZERS MARKET BY CONSUMABLES 2012-2022 ($ MILLION) 21
8.3. GLOBAL HEMOSTASIS ANALYZERS MARKET BY HEMOSTASIS ANALYZERS FOR POINT-OF-CARE TESTING 2012-2022 ($ MILLION) 21


CHAP 9. GLOBAL HEMOSTASIS ANALYZERS MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 22
9.1. GLOBAL HEMOSTASIS ANALYZERS MARKET BY REGION 2012-2022 ($ MILLION) 22
9.2. NORTH AMERICA 22
9.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
9.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
9.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 22
9.2.3.1. U.S. 22
9.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
9.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
9.2.3.2. CANADA 22
9.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
9.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
9.2.3.3. MEXICO 22
9.2.3.3.1. MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 22
9.2.3.3.2. MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 22
9.3. EUROPE 23
9.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
9.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
9.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 23
9.3.3.1. GERMANY 23
9.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
9.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
9.3.3.2. UK 23
9.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
9.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
9.3.3.3. FRANCE 23
9.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
9.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
9.3.3.4. SPAIN 23
9.3.3.4.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 23
9.3.3.4.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 23
9.3.3.5. ITALY 23
9.3.3.5.1. ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
9.3.3.5.2. ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
9.3.3.6. REST OF EUROPE 24
9.3.3.6.1. REST OF EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
9.3.3.6.2. REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
9.4. ASIA PACIFIC 24
9.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
9.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
9.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 24
9.4.3.1. CHINA 24
9.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
9.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
9.4.3.2. INDIA 24
9.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
9.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
9.4.3.3. JAPAN 24
9.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
9.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
9.4.3.4. SOUTH KOREA 24
9.4.3.4.1. SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
9.4.3.4.2. SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
9.4.3.5. REST OF APAC 25
9.4.3.5.1. REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
9.4.3.5.2. REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
9.5. REST OF THE WORLD 25
9.5.1. REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
9.5.2. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
9.5.3. REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 25
9.5.3.1. LATIN AMERICA 25
9.5.3.1.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
9.5.3.1.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
9.5.3.2. MIDDLE EAST AND AFRICA 25
9.5.3.2.1. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
9.5.3.2.2. MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25


CHAP 10. COMPETITIVE LANDSCAPE 26
10.1. ALERE, INC. 27
10.1.2. SCOT ANALYSIS 27
10.1.3. PRODUCT BENCHMARKING 27
10.1.4. STRATEGIC INITIATIVES 27
10.2. BECKMAN COULTER 27
10.2.2. SCOT ANALYSIS 27
10.2.3. PRODUCT BENCHMARKING 27
10.2.4. STRATEGIC INITIATIVES 27
10.3. BECTON DICKINSON 27
10.3.2. SCOT ANALYSIS 27
10.3.3. PRODUCT BENCHMARKING 27
10.3.4. STRATEGIC INITIATIVES 27
10.4. DIAGNOSTICA STAGO, INC. 27
10.4.2. PRODUCT BENCHMARKING 27
10.4.3. STRATEGIC INITIATIVES 27
10.5. HELENA LABORATORIES 27
10.5.2. SCOT ANALYSIS 27
10.5.3. PRODUCT BENCHMARKING 27
10.5.4. STRATEGIC INITIATIVES 27
10.6. HORIBA 27
10.6.2. SCOT ANALYSIS 27
10.6.3. PRODUCT BENCHMARKING 28
10.6.4. STRATEGIC INITIATIVES 28
10.7. INSTRUMENTATION LABORATORY WERFEN GROUP 28
10.7.2. SCOT ANALYSIS 28
10.7.3. PRODUCT BENCHMARKING 28
10.7.4. STRATEGIC INITIATIVES 28
10.8. INTERNATIONAL TECHNIDYNE CORPORATION 28
10.8.2. SCOT ANALYSIS 28
10.8.3. PRODUCT BENCHMARKING 28
10.8.4. STRATEGIC INITIATIVES 28
10.9. MINDRAY 28
10.9.2. SCOT ANALYSIS 28
10.9.3. PRODUCT BENCHMARKING 28
10.9.4. STRATEGIC INITIATIVES 28
10.10. NIHON KOHDEN CORPORATION (NIHON KOHDEN) 28
10.10.2. SCOT ANALYSIS 28
10.10.3. PRODUCT BENCHMARKING 28
10.10.4. STRATEGIC INITIATIVES 28
10.11. ROCHE DIAGNOSTICS 28
10.11.2. SCOT ANALYSIS 28
10.11.3. PRODUCT BENCHMARKING 28
10.11.4. STRATEGIC INITIATIVES 28
10.12. SIEMENS HEALTHCARE 29
10.12.2. SCOT ANALYSIS 29
10.12.3. PRODUCT BENCHMARKING 29
10.12.4. STRATEGIC INITIATIVES 29
10.13. SYSMEX CORPORATION 29
10.13.2. SCOT ANALYSIS 29
10.13.3. PRODUCT BENCHMARKING 29
10.13.4. STRATEGIC INITIATIVES 29
10.14. THERMO FISHER SCIENTIFIC, INC. 29
10.14.2. SCOT ANALYSIS 29
10.14.3. PRODUCT BENCHMARKING 29
10.14.4. STRATEGIC INITIATIVES 29
10.15. TRANSASIA BIO MEDICAL LTD. 29
10.15.2. SCOT ANALYSIS 29
10.15.3. PRODUCT BENCHMARKING 29
10.15.4. STRATEGIC INITIATIVES 29

TABLE 1 GLOBAL HEMOSTASIS ANALYZERS MARKET BY TYPE OF TEST 2012-2022 ($ MILLION) 30
TABLE 2 GLOBAL HEMOSTASIS ANALYZERS MARKET BY PROTHROMBIN TIME (PT/INR) TESTING KITS MARKET 2012-2022 ($ MILLION) 30
TABLE 3 GLOBAL HEMOSTASIS ANALYZERS MARKET BY ACTIVATED CLOTTING TIME (ACT/APTT) TESTING KITS MARKET 2012-2022 ($ MILLION) 30
TABLE 4 GLOBAL HEMOSTASIS ANALYZERS MARKET BY D DIMER TESTING KITS MARKET 2012-2022 ($ MILLION) 30
TABLE 5 GLOBAL HEMOSTASIS ANALYZERS MARKET BY FIBRINOGEN TESTING KITS MARKET 2012-2022 ($ MILLION) 30
TABLE 6 GLOBAL HEMOSTASIS ANALYZERS MARKET BY OTHERS TESTING KITS MARKET 2012-2022 ($ MILLION) 30
TABLE 7 GLOBAL HEMOSTASIS ANALYZERS MARKET BY TECHNOLOGY 2012-2022 ($ MILLION) 30
TABLE 8 GLOBAL HEMOSTASIS ANALYZERS MARKET BY MECHANICAL 2012-2022 ($ MILLION) 30
TABLE 9 GLOBAL HEMOSTASIS ANALYZERS MARKET BY OPTICAL 2012-2022 ($ MILLION) 30
TABLE 10 GLOBAL HEMOSTASIS ANALYZERS MARKET BY ELECTROCHEMICAL 2012-2022 ($ MILLION) 30
TABLE 11 GLOBAL HEMOSTASIS ANALYZERS MARKET BY OTHERS 2012-2022 ($ MILLION) 30
TABLE 12 GLOBAL HEMOSTASIS ANALYZERS MARKET BY END USERS 2012-2022 ($ MILLION) 30
TABLE 13 GLOBAL HEMOSTASIS ANALYZERS MARKET BY RESEARCH INSTITUTES 2012-2022 ($ MILLION) 30
TABLE 14 GLOBAL HEMOSTASIS ANALYZERS MARKET BY DIAGNOSTIC LABORATORIES 2012-2022 ($ MILLION) 30
TABLE 15 GLOBAL HEMOSTASIS ANALYZERS MARKET BY STANDALONE HOSPITALS 2012-2022 ($ MILLION) 30
TABLE 16 GLOBAL HEMOSTASIS ANALYZERS MARKET BY OTHER END USERS 2012-2022 ($ MILLION) 30
TABLE 17 GLOBAL HEMOSTASIS ANALYZERS MARKET BY PRODUCT TYPE 2012-2022 ($ MILLION) 31
TABLE 18 GLOBAL HEMOSTASIS ANALYZERS MARKET BY CLINICAL LABORATORY ANALYZERS 2012-2022 ($ MILLION) 31
TABLE 19 GLOBAL HEMOSTASIS ANALYZERS MARKET BY HEMOSSTASIS ANALYSERS 2012-2022 ($ MILLION) 31
TABLE 20 GLOBAL HEMOSTASIS ANALYZERS MARKET BY AUTOMATED HEMOSTASIS ANALYZERS 2012-2022 ($ MILLION) 31
TABLE 21 GLOBAL HEMOSTASIS ANALYZERS MARKET BY SEMI-AUTOMATED HEMOSTASIS ANALYZERS 2012-2022 ($ MILLION) 31
TABLE 22 GLOBAL HEMOSTASIS ANALYZERS MARKET BY MANUAL HEMOSTASIS ANALYZERS 2012-2022 ($ MILLION) 31
TABLE 23 GLOBAL HEMOSTASIS ANALYZERS MARKET BY CONSUMABLES 2012-2022 ($ MILLION) 31
TABLE 24 GLOBAL HEMOSTASIS ANALYZERS MARKET BY REAGENTS 2012-2022 ($ MILLION) 31
TABLE 25 GLOBAL HEMOSTASIS ANALYZERS MARKET BY STANDARDS, CONTROLS AND CALIBRATIONS 2012-2022 ($ MILLION) 31
TABLE 26 GLOBAL HEMOSTASIS ANALYZERS MARKET BY HEMOSTASIS ANALYZERS FOR POINT-OF-CARE TESTING 2012-2022 ($ MILLION) 31
TABLE 27 GLOBAL HEMOSTASIS ANALYZERS MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 31
TABLE 28 GLOBAL HEMOSTASIS ANALYZERS MARKET BY REGION 2012-2022 ($ MILLION) 31
TABLE 29 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 30 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 31 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 31
TABLE 32 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 31
TABLE 33 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 34 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 35 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 36 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 37 MEXICO MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 38 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 39 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 40 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 32
TABLE 41 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 42 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 43 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 44 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 45 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 46 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 47 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 48 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 49 ITALY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 32
TABLE 50 ITALY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 32
TABLE 51 REST OF EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 52 REST OF EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
TABLE 53 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 54 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
TABLE 55 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 33
TABLE 56 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 57 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
TABLE 58 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 59 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
TABLE 60 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 61 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
TABLE 62 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 63 SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
TABLE 64 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 65 REST OF APAC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
TABLE 66 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 67 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
TABLE 68 REST OF THE WORLD MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 34
TABLE 69 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
TABLE 70 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 34
TABLE 71 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
TABLE 72 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 34

FIGURE 1 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 2 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 4 MEXICO MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 5 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 6 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 7 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 8 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 9 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 10 REST OF EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
FIGURE 11 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 12 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 13 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 14 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 15 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 16 REST OF APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 17 REST OF THE WORLD MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 18 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
FIGURE 19 MIDDLE EAST AND AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)